Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

Clinical trial NCT00567502 · COMPLETED

Trial details

NCT number: NCT00567502
Sponsor: Shire
Status: COMPLETED
Study type: OBSERVATIONAL

Thrombocythemia, Essential

Start date: 2005-05-31
Primary completion: 2014-04-30
Enrollment: 3647

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.